These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Chemotherapeutic potential of phosphodiesterase inhibitors. Perry MJ; Higgs GA Curr Opin Chem Biol; 1998 Aug; 2(4):472-81. PubMed ID: 9736920 [TBL] [Abstract][Full Text] [Related]
4. An update on cyclic nucleotide phosphodiesterase (PDE) inhibitors: phosphodiesterases and drug selectivity. Gupta R; Kumar G; Kumar RS Methods Find Exp Clin Pharmacol; 2005 Mar; 27(2):101-18. PubMed ID: 15834463 [TBL] [Abstract][Full Text] [Related]
5. Clinical and molecular genetics of the phosphodiesterases (PDEs). Azevedo MF; Faucz FR; Bimpaki E; Horvath A; Levy I; de Alexandre RB; Ahmad F; Manganiello V; Stratakis CA Endocr Rev; 2014 Apr; 35(2):195-233. PubMed ID: 24311737 [TBL] [Abstract][Full Text] [Related]
6. Hormonal regulation of cyclic nucleotide phosphodiesterases. Conti M; Jin SL; Monaco L; Repaske DR; Swinnen JV Endocr Rev; 1991 Aug; 12(3):218-34. PubMed ID: 1657587 [No Abstract] [Full Text] [Related]
7. The inhibitory profile of Ibudilast against the human phosphodiesterase enzyme family. Gibson LC; Hastings SF; McPhee I; Clayton RA; Darroch CE; Mackenzie A; Mackenzie FL; Nagasawa M; Stevens PA; Mackenzie SJ Eur J Pharmacol; 2006 May; 538(1-3):39-42. PubMed ID: 16674936 [TBL] [Abstract][Full Text] [Related]
8. Cyclic nucleotide phosphodiesterases and human arterial smooth muscle cell proliferation. Rybalkin SD; Bornfeldt KE Thromb Haemost; 1999 Aug; 82(2):424-34. PubMed ID: 10605733 [No Abstract] [Full Text] [Related]
9. Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens. Seftel AD J Urol; 2005 Sep; 174(3):1043. PubMed ID: 16094045 [No Abstract] [Full Text] [Related]
10. Cyclic nucleotide phosphodiesterases (PDEs): coincidence detectors acting to spatially and temporally integrate cyclic nucleotide and non-cyclic nucleotide signals. Maurice DH; Wilson LS; Rampersad SN; Hubert F; Truong T; Kaczmarek M; Brzezinska P; Freitag SI; Umana MB; Wudwud A Biochem Soc Trans; 2014 Apr; 42(2):250-6. PubMed ID: 24646226 [TBL] [Abstract][Full Text] [Related]
11. Cyclic nucleotide specific phosphodiesterases of the kinetoplastida: a unified nomenclature. Kunz S; Beavo JA; D'Angelo MA; Flawia MM; Francis SH; Johner A; Laxman S; Oberholzer M; Rascon A; Shakur Y; Wentzinger L; Zoraghi R; Seebeck T Mol Biochem Parasitol; 2006 Jan; 145(1):133-5. PubMed ID: 16280178 [No Abstract] [Full Text] [Related]
13. Recent progress in understanding the hormonal regulation of phosphodiesterases. Conti M; Nemoz G; Sette C; Vicini E Endocr Rev; 1995 Jun; 16(3):370-89. PubMed ID: 7671852 [No Abstract] [Full Text] [Related]
14. Cyclic nucleotides and phosphodiesterases in platelets. Haslam RJ; Dickinson NT; Jang EK Thromb Haemost; 1999 Aug; 82(2):412-23. PubMed ID: 10605732 [No Abstract] [Full Text] [Related]
15. [Active role of phosphodiesterases in regulation of cyclic AMP metabolism in the thyroid gland (proceedings)]. Erneux C; Boeynaems JM; Van Sande J; Dumont JE Arch Int Physiol Biochim; 1976 Dec; 84(5):1070-2. PubMed ID: 65996 [No Abstract] [Full Text] [Related]
18. Phosphodiesterases and cyclic nucleotide signaling in endocrine cells. Conti M Mol Endocrinol; 2000 Sep; 14(9):1317-27. PubMed ID: 10976911 [No Abstract] [Full Text] [Related]
19. Recent advances in the study of Ca2+/CaM-activated phosphodiesterases: expression and physiological functions. Zhao AZ; Yan C; Sonnenburg WK; Beavo JA Adv Second Messenger Phosphoprotein Res; 1997; 31():237-51. PubMed ID: 9344255 [No Abstract] [Full Text] [Related]
20. Overview of PDEs and their regulation. Omori K; Kotera J Circ Res; 2007 Feb; 100(3):309-27. PubMed ID: 17307970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]